4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

Details for Australian Patent Application No. 2007354861 (hide)

Owner The Government of The United States of America as represented by the Secretary of The Department of Health and Human Services

Inventors Newman, Amy Hauck; Cyriac, George C.; Cao, Jianjing; Luedtke, Robert; Grundt, Peter

Agent Cullens

Pub. Number AU-A-2007354861

PCT Pub. Number WO2008/153573

Filing date 15 June 2007

Wipo publication date 18 December 2008

International Classifications

C07D 295/145 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/153573 Priority application(s): WO2008/153573

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007354870-Concentrate esmolol

2007354859-Apparatus and process for minimizing catalyst residence time in a reactor vessel